Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL551P is a pseudogene derived from the 7SL RNA gene family, widely present throughout the human genome as dispersed, noncoding elements[1][5][6][8]. The authentic 7SL RNA gene encodes the RNA core of signal recognition particle (SRP), a ribonucleoprotein essential for the targeting and translocation of newly synthesized proteins to the endoplasmic reticulum[3]. However, RN7SL551P itself is a truncated, non-functional DNA sequence created by the reverse transcription and integration of 7SL RNA-related elements back into the genome[5][6][8]. Pseudogenes like RN7SL551P do not produce functional RNA or protein products, are not actively transcribed, and are not considered molecular targets for drug development[1][5][6][8]. In certain research contexts, patterns of pseudogene expression and formation may have biomarker or prognostic value, especially in cancer profiling, though specific roles for RN7SL551P remain unconfirmed and it does not act as a molecular target[4]. Key points: - RN7SL551P is not a receptor, enzyme, transporter, or any other classical drug target. - It is non-functional and best classified as a pseudogene. - Clinical and biological relevance is limited to potential research applications in genomics/bioinformatics, not as a therapeutic target. - There may be confusion in target databases because 7SL RNA itself is a functional molecule, but RN7SL551P is not[1][5][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 551, pseudogene (RN7SL551P).